Benjamin Segal is a Neurology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 216 publications with 11,112 citations (h-index 56); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
395 W 12th Ave Fl 7
Columbus, OH 432101267
Telephone
614-293-4969Provider last certified this registry record 14 Nov 2024.
Clinical trials
- Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis
Sponsor: University of Utah
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
- EMD Serono, Inc.Program year20231 payment
- Biogen, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Potassium Channel Blocker100%Dalfampridine Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- Enhancement of RGC survival and Optic Nerve Regeneration by Cytokine Polarized Myeloid Cells
Ohio State University
FY2026$656,457R01EY036099 - Age-Associated Expansion of Natural IgM? Fcrl5? B Cell Clones: Drivers of Progressive MS and Targets for Therapy
Ohio State University
FY2026$611,634R01NS148278 - Enhancement of RGC survival and Optic Nerve Regeneration by Cytokine Polarized Myeloid Cells
Ohio State University
FY2025$665,243R01EY036099
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα–mediated lipid metabolism
Journal of Clinical Investigation
2020 - CNS-resident classical DCs play a critical role in CNS autoimmune disease
Journal of Clinical Investigation
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”